Results 11 to 20 of about 1,638 (145)

Corticosteroids for sepsis and septic shock: a meta-analysis of 18 RCTs with dose-stratified and fludrocortisone subgroup evaluation

open access: yesBMC Anesthesiology
Background The therapeutic benefit of corticosteroids in managing sepsis and septic shock remains controversial, particularly concerning optimal dosing strategies and the role of adjunctive fludrocortisone.
Lv Ruyuan   +3 more
doaj   +2 more sources

Cardiac and vascular effects of low-dose steroids during the early phase of septic shock: An echocardiographic study

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundLow-dose steroids are known to increase arterial pressure during septic shock through restoration of vasopressor response to norepinephrine. However, their effects on cardiac performance and ventriculo-arterial coupling (VAC) have never been ...
François Bagate   +15 more
doaj   +1 more source

Fludrocortisone-a treatment for tubulopathy post-paediatric renal transplantation : a national paediatric nephrology unit experience [PDF]

open access: yes, 2018
Calcineurin inhibitors post-renal transplantation are recognized to cause tubulopathies in the form of hyponatremia, hyperkalemia, and acidosis. Sodium supplementation may be required, increasing medication burden and potentially resulting in poor ...
Maxwell, H.   +7 more
core   +3 more sources

Evolution and Comparison Effects of Fludrocortisone and Betamethasone on Glucose and Lipid Profile in Rats

open access: yesActa Medica Iranica, 2020
Hyperglycemia may associate with improper use of glucocorticoids, impaired insulin function, or both, and is associated with many complications such as hyperlipidemia and Hyperglycemia.
Hamid Reza Reza Jamshidi   +1 more
doaj   +1 more source

Statistical Analysis Plan for the Fludrocortisone Dose Response Relationship in Septic Shock (FluDReSS) trial

open access: yes, 2023
FluDReSS is an open label randomised controlled clinical trial of three different dosing regimens of fludrocortisone in critically ill patients with septic shock compared to no fludrocortisone.
John Myburgh   +6 more
core   +1 more source

Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry

open access: yesEndocrine Connections, 2021
Objective: Treatment of classic congenital adrenal hyperplasia (CAH) is necessary to compensate for glucocorticoid/mineralocorticoid deficiencies and to suppress androgen excess.
Heike Hoyer-Kuhn   +12 more
doaj   +1 more source

Primary adrenal insufficiency - Addison's disease

open access: yesJournal of Education, Health and Sport, 2022
Introduction and purpose Addison's syndrome is defined as primary adrenal insufficiency, the symptoms of which result from hormonal deficiencies: glucocorticosteroids, mineralocorticosteroids and androgens.
Jakub Metelski   +4 more
doaj   +1 more source

Use of Deoxycorticosterone Pivalate by Veterinarians: A Western European Survey

open access: yesVeterinary Sciences, 2021
This study aims to gather knowledge about the use of deoxycorticosterone pivalate (DOCP) by Western European Veterinarians (WEV) in dogs with typical hypoadrenocorticism.
Rita Rebocho   +8 more
doaj   +1 more source

Does fludrocortisone treatment cause hypomagnesemia in children with primary

open access: yes, 2021
Background/aim: Aldosterone is a mineralocorticoid that secreted from adrenal glands and a known factor to increase magnesium excretion by direct and indirect effects on renal tubular cells.
ERBAŞ, İBRAHİM MERT   +13 more
core   +1 more source

Association of mortality with fludrocortisone addition to hydrocortisone treatment among septic shock patients: a propensity score matching analysis

open access: yesFrontiers in Medicine, 2023
BackgroundSeveral clinical trials of corticosteroids have been carried out in the treatment of septic shock, however, the therapeutic effect of the most widely used hydrocortisone is still controversial, and no studies have directly compared ...
Xiaoxiao Cheng   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy